...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Oxidative stress effects fibrinolytic system in dialysis uraemic patients.
【24h】

Oxidative stress effects fibrinolytic system in dialysis uraemic patients.

机译:氧化应激影响尿毒症患者的纤溶系统。

获取原文
获取原文并翻译 | 示例

摘要

INTRODUCTION: Enhanced oxidative stress (SOX) and changes in the fibrinolytic system are common in end-stage renal failure patients undergoing maintenance dialysis. This study attempted to verify the existence of a relationship between SOX documented by Cu/Zn superoxide dismutase (Cu/Zn SOD) and fibrinolysis analyzed by tissue-type plasminogen activator (tPA), urokinase-type plasminogen activator (uPA), plasminogen activator inhibitor 1 (PAI-1) and plasmin/antiplasmin (PAP) complexes in dialysis patients. MATERIALS AND METHODS: Twenty-seven patients on maintenance haemodialysis (HD) and 16 on maintenance peritoneal dialysis (CAPD) were examined together with 18 healthy controls. Pre-dialysis blood levels of all the parameters were determined using commercially ELISA kits. RESULTS: Cu/Zn SOD, uPA and PAP levels were increased in both groups of dialyzed patients compared to the controls. PAI-1 was significantly lower in CAPD subjects compared to HD subjects and control group. PAI-1/uPA ratio and PAI-1/tPA ratio were significantly decreased in CAPD and HD compared to controls, being significantly lower in CAPD patients relative to HD patients. In the patients, increased Cu/Zn SOD levels directly correlated with those of uPA (r=0.565, p<0.0001) and PAP (r=0.335, p<0.05); the fibrinolytic markers were also positively associated with each other (r=0.377, p<0.05). CONCLUSIONS: The positive association between Cu/Zn SOD and both uPA as well as PAP levels suggests a link between SOX and the fibrinolytic activity in dialysis patients. We hypothesize that increased SOX-mediated fibrinolytic activity may be a part of the counter-system against activation of blood coagulation in these patients.
机译:简介:接受维持性透析的终末期肾衰竭患者常见氧化应激(SOX)增强和纤溶系统改变。这项研究试图验证通过铜/锌超氧化物歧化酶(Cu / Zn SOD)记录的SOX与通过组织型纤溶酶原激活物(tPA),尿激酶型纤溶酶原激活物(uPA),纤溶酶原激活物抑制剂分析的纤维蛋白溶解之间的关系。 1(PAI-1)和纤溶酶/抗纤溶酶(PAP)复合物用于透析患者。材料与方法:对27例维持性血液透析(HD)患者和16例维持性腹膜透析(CAPD)患者以及18名健康对照者进行了检查。使用商业化的ELISA试剂盒测定透析前血液中所有参数的水平。结果:与对照组相比,两组透析患者的铜/锌超氧化物歧化酶,uPA和PAP水平均升高。与HD受试者和对照组相比,CAPD受试者的PAI-1显着降低。与对照组相比,CAPD和HD中PAI-1 / uPA比率和PAI-1 / tPA比率显着降低,相对于HD患者,CAPD患者中PAI-1 / uPA比率和PAI-1 / tPA比率显着降低。在患者中,铜/锌超氧化物歧化酶水平的升高与uPA(r = 0.565,p <0.0001)和PAP(r = 0.335,p <0.05)的水平直接相关。纤溶标记物之间也呈正相关(r = 0.377,p <0.05)。结论:Cu / Zn超氧化物歧化酶与uPA和PAP水平呈正相关,提示透析患者中​​SOX与纤溶活性之间存在联系。我们假设增加的SOX介导的纤溶活性可能是这些患者对抗凝血激活的反系统的一部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号